7- 13 gange (efter mindst 3 behandlingscykler) eller 16- 35 gange (efter en til flere behandlingscykler) højere end klinisk eksponering.
They were reported at exposure levels (Cmax) approximately 7 to 13 fold (after 3 or more dosing cycles) or 16 to 35 fold (after one or more dosing cycles) higher than clinical exposures.